Please note!

This fact brief was originally published as an experiment to test the concepts behind fact briefs.

Readers should be aware that while there is still a lot of useful information in fact briefs like this one, not all of them reflect Gigafact's current methods and standards for fact briefs. If you come across any that you feel are out of date, don't hesitate to contact us at support@gigafact.org.

FACT BRIEF

Can melatonin help treat COVID-19?

Monday, November 22, 2021

By Lisa Freedland

Copy link

Copy featured image

YES

Melatonin, a hormone that regulates sleep, which is made in the pineal gland but can also be taken as a supplement, has been observed to help reduce the severity of COVID-19 symptoms.

A June 2021 study found that COVID-19 patients given melatonin were discharged from the hospital sooner and returned to "baseline health" faster than those not given melatonin.

A September 2021 study found that melatonin improved symptoms and chances of survival in mice by reducing a type of pulmonary inflammation.

An October 2021 study reviewing melatonin's effects on humans found that "melatonin acts to prevent [oxygen deficiency], thereby improving COVID-19 prognosis."

Melatonin may also help prevent COVID-19 infection: A November 2020 study found that melatonin supplementation reduced the likelihood of a positive COVID-19 test by 28%, but authors noted that more studies are needed to evaluate its clinical efficacy.

This fact brief is responsive to conversations such as this one.

Sources

Archives of Medical Research Efficacy of a Low Dose of Melatonin as an Adjunctive Therapy in Hospitalized Patients with COVID-19: A Randomized, Double-blind Clinical Trial

Wiley Online Library Therapeutic potential of melatonin and melatonergic drugs on K18‐hACE2 mice infected with SARS‐CoV‐2

Journal of Inorganic Biochemistry Melatonin interferes with COVID-19 at several distinct ROS-related steps

PLOS A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19

ABOUT THE CONTRIBUTOR

Gigafact

Between 2020 and 2022, under close editorial supervision, Gigafact contracted a group of freelance writers and editors to test the concepts for fact briefs and provide inputs to our software development process. We call this effort Gigafact Foundry. Over the course of these two years, Gigafact Foundry writers published over 1500 fact briefs in response to claims they found online. Their important work forms the basis of Gigafact formats and editorial guidelines, and is available to the public on Gigafact.org. Readers should be aware that while there is still a lot of relevant information to be found, not all fact briefs produced by Gigafact Foundry reflect Gigafact's current methods and standards for fact briefs. If you come across any that you feel are out of date and need to be looked at with fresh eyes, don't hesitate to contact us at support@gigafact.org.

FACT BRIEF BY

Latest fact briefs

About fact briefs published on Gigafact

Fact briefs are short, credibly sourced summaries that offer “yes/no” answers in response to claims found online. They rely on publicly available, often primary source data and documents. Fact briefs are created by contributors to Gigafact —a nonprofit project looking to expand participation in fact-checking and protect the democratic process. See all fact briefs here.